Balasa Dinverno & Foltz LLC Elevance Health, Inc. Transaction History

Balasa Dinverno & Foltz LLC

$1.58 Billion
Q3 2022

A detailed history of Balasa Dinverno & Foltz LLC transactions in Elevance Health, Inc. stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 3,711 shares of ELV stock, worth $1.94 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

3,711

Previous 3,746 0.93%

Holding current value

$1.94 Million

Previous $1.81 Million 6.75%

% of portfolio

0.11%

Previous 0.11%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$445.98 - $507.0 $15,609 - $17,745	-35 Reduced 0.93%	3,711 $1.69 Million
Q2 2022 Aug 09, 2022	SELL	$444.32 - $529.84 $17,772 - $21,193	-40 Reduced 1.06%	3,746 $1.81 Million
Q1 2022 Apr 25, 2022	BUY	$428.44 - $502.48 $337,610 - $395,954	788 Added 26.28%	3,786 $1.86 Million
Q4 2021 Jan 26, 2022	SELL	$370.08 - $467.67 $39,228 - $49,573	-106 Reduced 3.41%	2,998 $1.39 Million
Q3 2021 Oct 26, 2021	BUY	$357.51 - $398.13 $41,828 - $46,581	117 Added 3.92%	3,104 $1.16 Million
Q2 2021 Jul 23, 2021	SELL	$352.19 - $401.9 $3,874 - $4,420	-11 Reduced 0.37%	2,987 $1.14 Million
Q1 2021 Apr 29, 2021	SELL	$287.7 - $371.31 $111,339 - $143,696	-387 Reduced 11.43%	2,998 $1.08 Million
Q4 2020 Jan 26, 2021	BUY	$270.17 - $333.15 $65,651 - $80,955	243 Added 7.73%	3,385 $1.09 Million
Q3 2020 Nov 10, 2020	BUY	$245.73 - $284.63 $40,545 - $46,963	165 Added 5.54%	3,142 $844,000
Q2 2020 Aug 07, 2020	SELL	$203.3 - $300.59 $28,665 - $42,383	-141 Reduced 4.52%	2,977 $783,000
Q1 2020 Apr 30, 2020	SELL	$174.68 - $307.74 $106,380 - $187,413	-609 Reduced 16.34%	3,118 $708,000
Q4 2019 Jan 22, 2020	SELL	$234.82 - $306.42 $157,799 - $205,914	-672 Reduced 15.28%	3,727 $1.13 Million
Q3 2019 Nov 06, 2019	BUY	$237.69 - $310.48 $16,162 - $21,112	68 Added 1.57%	4,399 $1.06 Million
Q2 2019 Aug 07, 2019	SELL	$236.25 - $293.76 $137,970 - $171,555	-584 Reduced 11.88%	4,331 $1.22 Million
Q1 2019 May 10, 2019	BUY	$248.42 - $317.42 $53,658 - $68,562	216 Added 4.6%	4,915 $1.41 Million
Q4 2018 Feb 04, 2019	BUY	$249.0 - $296.25 $222,357 - $264,551	893 Added 23.46%	4,699 $1.23 Million
Q3 2018 Oct 24, 2018	BUY	$238.27 - $274.12 $41,935 - $48,245	176 Added 4.85%	3,806 $1.04 Million
Q2 2018 Aug 01, 2018	BUY	$220.13 - $245.16 $21,352 - $23,780	97 Added 2.75%	3,630 $864,000
Q1 2018 Apr 23, 2018	BUY	$215.63 - $258.19 $21,778 - $26,077	101 Added 2.94%	3,533 $776,000
Q4 2017 Feb 05, 2018	BUY	$183.76 - $234.96 $18,743 - $23,965	102 Added 3.06%	3,432 $772,000
Q3 2017 Oct 18, 2017	BUY	$181.44 - $197.43 $604,195 - $657,441	3,330	3,330 $632,000

Others Institutions Holding ELV

# of Institutions

1,866

Shares Held

203M

Call Options Held

1.02M

Put Options Held

1.01M

View Full List

About Elevance Health, Inc.

Ticker ELV
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 240,000,992
Market Cap $126B
Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....

More about ELV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.

Account

Balasa Dinverno & Foltz LLC Elevance Health, Inc. Transaction History